Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Confronting the diagnosis of multiple sclerosis: a qualitative study of patient experiences.
[Cognitive impairment in demyelinating disease].
Ampyra 10mg beats 5mg, but weak overall results net neutral for ACOR
Drug record: Amiloride
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.
Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome.
Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells.
Progressive multiple sclerosis: The treatment gap.
Immunohistochemical detection of sphingosine-1-phosphate and sphingosine kinase-1 in human tissue samples.
Product Insert, Amiloride HCl Tablets
Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.
Epidural blood patch in a patient with multiple sclerosis: is it safe?
Phenytoin protects central axons in experimental autoimmune encephalomyelitis.
Management of children with multiple sclerosis.
Autoinflammatory grey matter lesions in humans: cortical encephalitis, clinical disorders, experimental models.
Incidence of Mood or Anxiety Disorders in Children of Parents with Multiple Sclerosis.
Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation.
Treating multiple sclerosis with monoclonal antibodies: a 2013 update.
Effects of Panax ginseng in Neurodegenerative Diseases.
Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells.
Placebo? no thanks, it might be bad for me!
A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis.
Early pathological alterations of lower lumbar cords detected by ultrahigh-field MRI in a mouse multiple sclerosis model.
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS.
The "liberation procedure" for multiple sclerosis: sacrificing science at the altar of consumer demand.
Pages
« first
‹ previous
…
123
124
125
126
127
128
129
130
131
…
next ›
last »